Ramboll was appointed to deliver comprehensive technical advice and assistance in connection with a strategically important Purification Plant set up for Novo Nordisk in Copenhagen, Denmark. The plant will increase the capacity for the manufacturing of active diabetes medicines in line with the Novo Nordisk development programme.
The Purification Plant, which has a total area of 2,700 square meters, is a so-called 'best practice' facility. The project involves, in the first instance, the establishment of a test plant with one purification line with the option of further expansion of the plant to double the size for additional capacity.
The Plant will be fully operational in 2016 and will be driven by CMC Supply (Chemistry, Manufacturing and Control Supply), key to the Novo Nordisk research programme. CMC Supply develops, manufactures and formulates all new protein and peptide processes in Novo Nordisk.
Ramboll delivers full Engineering and Architectural services, which includes the total 'CSA-package' (Civil, Structural and Architectural), a 'BS-package' (Building Services) as well as construction management and technical supervision which ranges from the Basic and Detailed Designs to EPCM services (Engineering, Procurement and Construction Management).